RedHill Biopharma Limited
Pre-Approval PRO BETAStale Activity
No new clinical trials started in 2+ years. Activity may be declining or company may be focusing on existing programs. Last trial started: 2/16/2021
Pipeline by Phase
Therapeutic Focus
Clinical Trials (16)
RHB-204 for the Treatment of Pulmonary Mycobacterium Avium Complex Disease
Started: 12/1/2020
Open Label Efficacy and Safety of Anti-MAP (Mycobacterium Avium Ssp. Paratuberculosis) Therapy in Adult Crohn's Disease
Started: 3/18/2017
Efficacy and Safety of Anti-MAP Therapy in Adult Crohn's Disease
Started: 9/1/2013
ERADICATE Hp2 - Treating Helicobacter Pylori With RHB-105 Compared to Active Comparator
Started: 6/18/2017
ERADICATE Hp - Treating Helicobacter Pylori With RHB-105
Started: 11/1/2013
BEKINDA (Ondansetron 24 mg Bimodal Release Tablets) for Vomiting Due to Presumed Acute Gastroenteritis or Gastritis
Started: 12/8/2014
Opaganib, a Sphingosine Kinase-2 (SK2) Inhibitor in COVID-19 Pneumonia
Started: 8/21/2020
A Study of ABC294640 Alone and in Combination With HCQ Sulfate in the Treatment of Advanced Cholangiocarcinoma
Started: 3/7/2018
Upamostat, a Serine Protease Inhibitor, or Placebo for Treatment of COVID-19 Disease
Started: 2/16/2021
A Study of Opaganib in Coronavirus Disease 2019 Pneumonia
Started: 7/2/2020
Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial of BEKINDA (Ondansetron 12 mg Bimodal Release Tablets) for Diarrhea Predominant Irritable Bowel Syndrome (IBS-D)
Started: 5/19/2016
Proof of Concept Study of RHB-104 as Add-On Therapy to Interferon Beta-1a in Relapsing Remitting Multiple Sclerosis (RRMS)
Started: 6/1/2013
ABC294640 (Opaganib) in Refractory / Relapsed Multiple Myeloma
Started: 12/13/2016
Treatment of COVID-19 With Opaganib in Patients With Pneumonia Requiring Oxygen
Started: 8/1/2020
ABC294640 in Treating Patients With Advanced Solid Tumors
Started: 8/1/2011
Early Phase Evaluation of ABC294640 in Patients With Refractory/Relapsed Diffuse Large B-cell Lymphoma or Kaposi Sarcoma
Started: 7/1/2014